Avadel shareholders approve Alkermes acquisition Jan 12, 2026 04:06PM
Avadel board deems Lundbeck's $2.4 billion bid superior to Alkermes deal Nov 17, 2025 05:52AM
Alkermes responds to competing offer for Avadel from Lundbeck Nov 14, 2025 07:45AM
Avadel receives $23 per share takeover bid from Lundbeck Nov 14, 2025 05:45AM
Avadel Pharma (AVDL) Misses Q3 EPS by 7c Nov 4, 2025 05:36PM


Oct 28, 2025 03:48AM UBS Downgrades Avadel Pharmaceuticals (AVDL) to Neutral
Oct 23, 2025 07:39AM H.C. Wainwright Downgrades Avadel Pharmaceuticals (AVDL) to Neutral
Oct 23, 2025 06:59AM Leerink Partners Downgrades Avadel Pharmaceuticals (AVDL) to Market Perform
Oct 22, 2025 03:19PM RBC Capital on Jazz Pharmaceuticals (JAZZ): 'we would be buyers on the potential upcoming positive ph.III zanidatimab data in GEA'
Oct 22, 2025 10:06AM Jefferies Downgrades Avadel Pharmaceuticals (AVDL) to Hold
Oct 22, 2025 09:20AM Needham Downgrades Avadel Pharmaceuticals (AVDL) to Hold
Oct 22, 2025 06:56AM Avadel Pharma (AVDL) Halted, News Pending
Oct 22, 2025 06:56AM Increasing unusual call option volume: BYND AVDL REI GLL LEVI BRR ALC ACHV
Oct 22, 2025 06:54AM Avadel and Jazz Pharmaceuticals settle patent litigation for $90 million
Sep 16, 2025 02:40PM Avadel Pharma (AVDL) 5K contracts of October 12.50 puts trade
Sep 5, 2025 06:43AM Avadel Pharmaceuticals (AVDL) PT Raised to $36 at H.C. Wainwright
Sep 3, 2025 04:30PM Avadel licenses valiloxybate from XWPharma for $20 million upfront
Aug 21, 2025 07:29AM Avadel Pharmaceuticals (AVDL) PT Raised to $20 at UBS
Aug 8, 2025 07:17AM Avadel Pharmaceuticals (AVDL) PT Raised to $24 at H.C. Wainwright
Aug 7, 2025 07:05AM Avadel Pharma (AVDL) Tops Q2 EPS by 7c, Beats on Revenue
Jul 14, 2025 07:02AM ASL Strategic Value Fund urges Avadel shareholders to vote against directors
Jun 30, 2025 07:04AM ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders (AVDL)
Jun 5, 2025 07:31AM Avadel Pharma (AVDL) Receives Orphan Drug Designation from FDA for LUMRYZ for ER Oral Suspension for the Treatment of Idiopathic Hypersomnia
May 13, 2025 04:15PM Avadel Pharma (AVDL) Appoints Susan Rodriguez as COO
May 7, 2025 07:01AM Avadel Pharma (AVDL) Tops Q1 EPS by 1c ; Offers Guidance
May 6, 2025 12:32PM Avadel Pharma (AVDL) announces favorable ruling in LUMRYZ case
Apr 8, 2025 01:30PM Avadel Pharma (AVDL) Provides Update at Needham Virtual Healthcare Conference
Mar 4, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Avadel Pharmaceuticals (AVDL)
Mar 3, 2025 12:35PM Oppenheimer Reiterates Outperform Rating on Avadel Pharmaceuticals (AVDL)
Mar 3, 2025 07:04AM Avadel Pharma (AVDL) Misses Q4 EPS by 3c ; Offers Guidance
Feb 24, 2025 08:03AM Avadel Pharma (AVDL) Appoints Kevin Springman as VP of Sales
Feb 11, 2025 02:58AM Deutsche Bank Starts Avadel Pharmaceuticals (AVDL) at Buy
Feb 10, 2025 09:00AM ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL) Board
Jan 10, 2025 07:54AM Avadel Pharmaceuticals (AVDL) PT Slashed to $13 at Piper Sandler; 'Lowering PT But Staying Bullish'
Jan 8, 2025 04:48PM After-hours movers: NVIDIA, Costco, Penguin Solutions, Avadel Pharma
Jan 8, 2025 04:17PM Avadel Pharma (AVDL) Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
Dec 11, 2024 07:35AM Piper Sandler Provides 'Expert Perspectives On Orexin Agonists And An Evolving Sleep/Wake Space'
Nov 13, 2024 06:53AM Avadel Pharmaceuticals (AVDL) PT Lowered to $25 at H.C. Wainwright
Nov 12, 2024 07:01AM Avadel Pharma (AVDL) Tops Q3 EPS by 5c
Oct 31, 2024 07:54AM Avadel Pharmaceuticals (AVDL) PT Raised to $30 at Oppenheimer
Oct 31, 2024 07:01AM Avadel Pharma (AVDL) Announces Favorable Ruling in Administrative Procedure Act Litigation
Oct 21, 2024 07:40AM H.C. Wainwright Reiterates Buy Rating on Avadel Pharmaceuticals (AVDL)
Oct 17, 2024 09:42AM Avadel Pharma (AVDL) Announces FDA Approval of LUMRYZ Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with N
Sep 3, 2024 08:04AM Avadel Pharma (AVDL) Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ Dosing
Aug 29, 2024 08:19AM H.C. Wainwright Reiterates Buy Rating on Avadel Pharmaceuticals (AVDL)
Aug 28, 2024 10:22AM Increasing unusual put option volume: AVDL BBWI OIH HA FL JWN BCS KSS KMX LUNR BEN STNE
Aug 28, 2024 07:12AM Avadel Pharma (AVDL) announces court decision allowing commercial launch of LUMRYZ in narcolepsy to proceed without interruption
Aug 8, 2024 07:02AM Avadel Pharma (AVDL) Tops Q2 EPS by 4c
Apr 2, 2024 10:00AM Here are Oppenheimer’s best Smidcap ideas